Xilio Therapeutics's total assets for Q3 2025 were $133.69M, a decrease of -0.09% from the previous quarter. XLO total liabilities were $141.79M for the fiscal quarter, a 11.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.